<DOC>
	<DOCNO>NCT02646644</DOCNO>
	<brief_summary>In individual cancer patient extensive genetic phenotypic variation exists within tumor lesion . Tumour load NET patient measure fluorine-18-L-dihydroxyphenylalaninepositron emission tomography ( 18F-DOPA-PET ) scan . This aim study investigate heterogeneity tumor lesion within patient intestinal NET determine difference tracer uptake measure 18F- DOPA-PET scan retrospectively .</brief_summary>
	<brief_title>Heterogeneity Metastatic Neuroendocrine Tumors Determined With 18F-dihydroxyphenylalanine-PET /CT , Retrospective Analysis</brief_title>
	<detailed_description>In individual cancer patient extensive genetic phenotypic variation exists within tumor lesion . Tumour load NET patient measure fluorine-18-L-dihydroxyphenylalanine positron emission tomography ( 18F-DOPA-PET ) scan . This aim study investigate heterogeneity tumor lesion within patient intestinal NET determine difference tracer uptake measure 18F- DOPA-PET scan retrospect .</detailed_description>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Dihydroxyphenylalanine</mesh_term>
	<criteria>age â‰¥18 year diagnosis intestinal NET diagnose dedicate NET specialist one positive lesion 18FDOPAPET scan . available CTscan within 6 month 18FDOPAPETscan . clinical data available UMCG , besides result DOPA PET scan .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>